135 related articles for article (PubMed ID: 38114462)
1. Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.
Gagnon MF; Penheiter AR; Harris F; Sadeghian D; Johnson SH; Karagouga G; McCune A; Zepeda-Mendoza C; Greipp PT; Xu X; Ketterling RP; McPhail ED; King RL; Peterson JF; Vasmatzis G; Baughn LB
Blood Cancer J; 2023 Dec; 13(1):190. PubMed ID: 38114462
[No Abstract] [Full Text] [Related]
2. Clinical impact of 5
Tang G; Li S; Toruner GA; Jain P; Tang Z; Hu S; Xu J; Cheng J; Robinson M; Vega F; Medeiros LJ
Cancer Genet; 2023 Apr; 272-273():1-8. PubMed ID: 36566629
[TBL] [Abstract][Full Text] [Related]
3.
Tourneret A; Alame M; Rigau V; Bauchet L; Fabbro M; De Oliveira L; Cacheux V; Costes V; Lacheretz-Szablewski V
J Clin Pathol; 2021 Oct; 74(10):650-656. PubMed ID: 32912960
[TBL] [Abstract][Full Text] [Related]
4. Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas.
Cassidy DP; Chapman JR; Lopez R; White K; Fan YS; Casas C; Severson EA; Vega F
Am J Clin Pathol; 2020 Feb; 153(3):353-359. PubMed ID: 31872861
[TBL] [Abstract][Full Text] [Related]
5. Elucidating a false-negative
Peterson JF; Pitel BA; Smoley SA; Vasmatzis G; Smadbeck JB; Greipp PT; Ketterling RP; Macon WR; Baughn LB
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160360
[TBL] [Abstract][Full Text] [Related]
6. Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer.
Lim SM; Chang H; Cha YJ; Liang S; Tai YC; Li G; Pestova E; Policht F; Perez T; Soo RA; Park WY; Kim HR; Shim HS; Cho BC
Lung Cancer; 2017 Sep; 111():79-83. PubMed ID: 28838404
[TBL] [Abstract][Full Text] [Related]
7. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
Smadbeck J; Peterson JF; Pearce KE; Pitel BA; Figueroa AL; Timm M; Jevremovic D; Shi M; Stewart AK; Braggio E; Riggs DL; Bergsagel PL; Vasmatzis G; Kearney HM; Hoppman NL; Ketterling RP; Kumar S; Rajkumar SV; Greipp PT; Baughn LB
Blood Cancer J; 2019 Dec; 9(12):103. PubMed ID: 31844041
[TBL] [Abstract][Full Text] [Related]
8. Integrated Genomic DNA/RNA Profiling vs Fluorescence in Situ Hybridization in the Detection of MYC and BCL2 (and BCL6) Rearrangements in Large B-Cell Lymphomas: Updates Amid the New WHO Classification of Lymphoid Neoplasms.
de Lima Guido LP; Chapman J; Cassidy DP
Am J Clin Pathol; 2023 Jul; 160(1):41-48. PubMed ID: 36881639
[TBL] [Abstract][Full Text] [Related]
9. Multi-break rearrangements and breakpoint re-uses: from circular to linear genomes.
Alekseyev MA
J Comput Biol; 2008 Oct; 15(8):1117-31. PubMed ID: 18788907
[TBL] [Abstract][Full Text] [Related]
10. High-resolution architecture and partner genes of
Chong LC; Ben-Neriah S; Slack GW; Freeman C; Ennishi D; Mottok A; Collinge B; Abrisqueta P; Farinha P; Boyle M; Meissner B; Kridel R; Gerrie AS; Villa D; Savage KJ; Sehn LH; Siebert R; Morin RD; Gascoyne RD; Marra MA; Connors JM; Mungall AJ; Steidl C; Scott DW
Blood Adv; 2018 Oct; 2(20):2755-2765. PubMed ID: 30348671
[TBL] [Abstract][Full Text] [Related]
11. FGFR1 disruption identified by whole genome sequencing in a male with a complex chromosomal rearrangement and hypogonadotropic hypogonadism.
Yamoto K; Okamoto S; Fujisawa Y; Fukami M; Saitsu H; Ogata T
Am J Med Genet A; 2018 Jan; 176(1):139-143. PubMed ID: 29160040
[No Abstract] [Full Text] [Related]
12. TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing.
Kawashima M; Ueda Y; Kurihara S; Hiyama E
Int J Clin Oncol; 2020 Dec; 25(12):2166-2174. PubMed ID: 32894394
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R
Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569
[TBL] [Abstract][Full Text] [Related]
14. Human whole genome sequencing in South Africa.
Glanzmann B; Jooste T; Ghoor S; Gordon R; Mia R; Mao J; Li H; Charls P; Douman C; Kotze MJ; Peeters AV; Loots G; Esser M; Tiemessen CT; Wilkinson RJ; Louw J; Gray G; Warren RM; Möller M; Kinnear C
Sci Rep; 2021 Jan; 11(1):606. PubMed ID: 33436733
[TBL] [Abstract][Full Text] [Related]
15. Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma.
Jang JS; Wang X; Vedell PT; Wen J; Zhang J; Ellison DW; Evans JM; Johnson SH; Yang P; Sukov WR; Oliveira AM; Vasmatzis G; Sun Z; Jen J; Yi ES
J Thorac Oncol; 2016 Nov; 11(11):1891-1900. PubMed ID: 27343444
[TBL] [Abstract][Full Text] [Related]
16. Severe hemophilia A caused by an unbalanced chromosomal rearrangement identified using nanopore sequencing.
Chatron N; Schluth-Bolard C; Frétigny M; Labalme A; Vilchez G; Castet SM; Négrier C; Sanlaville D; Vinciguerra C; Jourdy Y
J Thromb Haemost; 2019 Jul; 17(7):1097-1103. PubMed ID: 31021037
[TBL] [Abstract][Full Text] [Related]
17. Random matrix approach to the distribution of genomic distance.
Alexeev N; Zograf P
J Comput Biol; 2014 Aug; 21(8):622-31. PubMed ID: 24650202
[TBL] [Abstract][Full Text] [Related]
18. Unexpected effects of different genetic backgrounds on identification of genomic rearrangements via whole-genome next generation sequencing.
Chen Z; Gowan K; Leach SM; Viboolsittiseri SS; Mishra AK; Kadoishi T; Diener K; Gao B; Jones K; Wang JH
BMC Genomics; 2016 Oct; 17(1):823. PubMed ID: 27769169
[TBL] [Abstract][Full Text] [Related]
19. Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation.
Santos Gda C; Saieg MA; Ko HM; Geddie WR; Boerner SL; Craddock KJ; Crump M; Bailey D
Cancer Cytopathol; 2015 Jul; 123(7):413-20. PubMed ID: 25807917
[TBL] [Abstract][Full Text] [Related]
20. Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
Hillman RT; Chisholm GB; Lu KH; Futreal PA
J Natl Cancer Inst; 2018 Mar; 110(3):265-72. PubMed ID: 29584920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
